🇺🇸 FDA

Company profile · Sponsor

Peking

Peking University Third Hospital

C8018FA · NMPA pharma CN
Pipeline
15
Drugs
0
Patents
0

Quick answer

Peking (C8018FA) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C8018FA
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (15)

Search pipeline →

  1. Triptolide Wilfordii

    Peking

    HIV-infection/AIDS

    phase 3 small molecule completed

    1 trial

  2. 68Ga-NY104 PET/CT

    Peking

    Clear Cell Renal Cell Carcinoma

    phase 2 other active

    1 trial

  3. 68Ga-Pentixafor

    Peking

    Cushing s Syndrome

    phase 2 small molecule active

    1 trial

  4. Glofitamab

    Peking

    MCL

    phase 2 small molecule active

    1 trial

  5. Luveris

    Peking

    Infertility

    phase 2 small molecule active

    1 trial

  6. Roxadustat

    Peking

    Coronary Artery Bypass

    phase 2 small molecule terminated

    1 trial

  7. recombinant human endostatin

    Peking

    Melanoma

    phase 2 small molecule active

    1 trial

  8. Dexmedetomidine

    Peking

    Breast Cancer

    approved small molecule completed

    1 trial

  9. Dexmedetomidine

    Peking

    Aged

    approved small molecule completed

    1 trial

  10. ticagrelor + ASA

    Peking

    Cerebrovascular Accident

    approved small molecule completed

    1 trial

  11. Combination of targeted biopsy and systematic biopsy

    Peking

    Prostate Cancer

    other completed

    1 trial

  12. ERA

    Peking

    Infertility, Female

    other active

    1 trial

  13. Protocol-based management of perioperative antithrombotic therapy

    Peking

    Antithrombotic Therapy

    small molecule active

    1 trial

  14. chlorhexidine acetate gargle

    Peking

    Esophageal Cancer

    small molecule active

    1 trial

  15. glucocorticoid plus iguratimod

    Peking

    Autoimmune Diseases

    small molecule active

    1 trial

Frequently asked questions

What is Peking?

Peking (C8018FA) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Peking sponsor?

We track 15 ClinicalTrials.gov-linked programs for Peking, including Triptolide Wilfordii and 14 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Peking company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.